DÜSSELDORF, Germany — LenioBio GmbH, a TechBio company commercializing its ALiCE® cell-free protein expression platform, today announced a collaborative agreement with Twist Bioscience Corporation. The collaboration will integrate our ALiCE® platform with Twist’s DNA manufacturing and automation capabilities to accelerate the design–build–test cycle for protein expression services—delivering experimental results back to customers’ and partners’ AI […]
Toronto companies partner to provide an integrated platform that runs the complete clinical genetics workflow, from patient intake to diagnostic report, entirely on Canadian infrastructure. TORONTO, Ontario — DNAstack and PhenoTips today announced an integrated platform that runs clinical genetics workflows, from patient intake and phenotyping to genomic interpretation and diagnostic report, entirely on Canadian infrastructure. At a time […]
Licensed purification methods address a key challenge in producing high‑purity, 100+nt RNA constructs used in CRISPR and functional genomics Boulder, CO – Cirena Inc. licensed a validated long RNA purification technology from Agilent Technologies, Inc. as it looks to expand access to high purity RNA constructs used in genome editing and functional genomics research. The […]
Licensed purification methods address a key challenge in producing high‑purity, 100+nt RNA constructs used in CRISPR and functional genomics Boulder, CO – Cirena Inc. licensed a validated long RNA purification technology from Agilent Technologies, Inc. as it looks to expand access to high purity RNA constructs used in genome editing and functional genomics research. The […]
Combines validated scientific engines with accelerated computing and AI to enable more scalable, integrated modeling workflows across the drug development lifecycle RESEARCH TRIANGLE PARK, N.C. — Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus” or the “Company”), a global leader in model-informed and AI-accelerated drug development that advances biopharma innovation, today announced the launch of a […]
Scientists can now design biological experiments, place orders with external lab partners, and receive structured results, without leaving Benchling SAN FRANCISCO — Benchling, the AI platform for biotech R&D, today announced the launch of direct ordering for biological materials and CRO services. This update integrates industry leaders Twist Bioscience for gene synthesis, antibody expression, binding, developability and other […]
AWS technologies enhance the speed, scale, and analytical power of BC Platforms’ trusted research environments, enabling global collaboration on multi-modal real-world data while supporting European Health Data Space (EHDS) readiness across Europe ZURICH — BC Platforms, a global leader in healthcare data, technology, and analytics, announced today that it has signed a Strategic Collaboration Agreement with […]
MARLBOROUGH, Mass. — SCIEX, a Danaher company and leader in life science analytical technologies, highlighted six industry collaborations as it continues to build an integrated software environment with SCIEX software solutions. The result is a scalable, analytically rigorous software environment engineered to meet the evolving and complex needs of modern labs. By unifying instrument control, […]
New analysis suite helps cell engineering teams benchmark target identity, detect off-target states, and prioritize protocol improvements ST. LOUIS — CapyBio, a cell identity tools and services company, today announced the launch of three new commercial analysis services: Capybara™ Benchmarking Analysis, Capybara Advanced Analysis, and CellOracle™ Differentiation Optimization Analysis. Together, these services help cell engineering teams […]
IRVINE, Calif. – GeneTex, a multinational recombinant antibody manufacturer, is excited to announce the formalization of a collaborative relationship with the renowned Human Protein Atlas (HPA), a peerless, open-access multi-laboratory organization whose primary goal is to establish a comprehensive map of the human proteome using an integrated omics approach involving antibody-based proteomics and transcriptomics. The HPA’s importance […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
